SMTL ID : 7l5p.2 (1 other biounit)

Crystal structure of the covalently bonded complex of rilzabrutinib with BTK

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.14 Å

Oligo State

monomer

Ligands

1 x R1L: (2E)-2-{(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl}-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile(Covalent)

R1L.1: 22 residues within 4Å: Chain A: L.20, G.21, T.22, G.23, V.28, A.40, K.42, M.61, L.72, I.84, T.86, E.87, Y.88, M.89, G.92, C.93, N.96, R.137, L.140, S.150, D.151, F.152 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.28, A:K.42, A:L.72, A:I.84, A:R.137 Hydrogen bonds: A:T.86, A:E.87, A:M.89, A:C.93 pi-Stacking: A:F.152

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 5 residues within 4Å: Chain A: E.57, F.129, L.130, R.132, G.153 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.128, A:L.130 EDO.3: 3 residues within 4Å: Chain A: Y.210, E.211, R.212 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.212 Water bridges: A:Y.210, A:E.211

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.4: 2 residues within 4Å: Chain A: G.21, T.22 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.22

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Owens, T.D., The Discovery Rilzabrutinib (PRN1008): A Reversible Covalent BTK Inhibitor for Immune Mediated Diseases. To Be Published

Release Date

2022-06-29

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence